Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the mechanism and side effects of smoothened inhibitors for advanced basal cell carcinoma, reporting no new clinical results and highlighting current management strategies for these adverse events.

This case report describes a patient with Birt-Hogg-Dube syndrome exhibiting multiple fibrofolliculomas, acrochordons, and renal oncocytoma.

This review evaluates androgenetic alopecia treatments, highlighting both current options like minoxidil, finasteride, and low-level light therapy, and emerging therapies such as platelet-rich plasma and complex combination treatments, noting their potential and challenges.

This review discusses the advancements in using "soft" colloidal nanocarriers for delivering photosensitive agents and highlights their potential applications in treating diseases like cancer, but it reports no new clinical results.

This review highlights the promising biomedical applications of marine-derived polysaccharides, proteins, and peptides, particularly in drug delivery and wound healing. It discusses their potential as biomaterials in creating nanocarriers, hydrogels, and more, alongside fabrication strategies, regulatory challenges, and sustainability considerations.

This study analyzed reports from the FDA Adverse Event Reporting System and observed an upward trend in suicidality-related safety signals among young male finasteride users since 2019, peaking in 2022, highlighting emerging psychiatric safety concerns and the need for vigilant monitoring of this population.

This study validated that six out of seven tested topical formulations for alopecia are compatible for 6-month use, suggesting they may be practical for compounding pharmacies.

This article discusses various hair-related issues, such as dandruff and hair loss, and outlines potential solutions, highlighting the need for personalized treatments and cost-effective approaches based on specific hair problems.

This review concludes that low-level laser therapy is the most supported physical treatment for androgenetic alopecia, but other therapies like nonablative laser treatments and combinations including PEMF may also be promising.

This study found that melatonin-loaded vitamin C-based nanovesicles improved hair thickness, density, and reduced hair loss in patients with androgenic alopecia more effectively than melatonin solution.

This study found that lead treatment enhances the imaging of organized hair lipid structures, revealing their orientation and possible composition as lead and calcium soaps, with potential applications in various fields.

This review discusses the potential of nanotechnology in treating idiopathic pulmonary fibrosis by targeting abnormal alveolar epithelial cells and reports no new clinical results.

Oxidative stress and mitophagy play key roles in hair loss, suggesting potential treatment targets.

In this study, baicalin, a component of Baikal skullcap, was found to inhibit necroptosis in a cellular model of toxic epidermal necrolysis, suggesting it may be effective against severe drug-induced skin eruptions.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

This review describes the role of iron deficiency in hair loss and explores the management of diffuse alopecia, emphasizing the potential of a new iron-based dietary supplement but reports no new clinical results.

This study found that a significant portion of students with dandruff practiced self-medication, often using ketoconazole shampoo, which many reported caused hair loss.

In this study of hair loss treatments, patients using a combined regimen of minoxidil, finasteride, and supplements showed significant hair density and caliber improvements within 2-4 months, sustaining these gains for up to two years.

This article reviews current diagnostic and treatment approaches for androgenetic alopecia but reports no new results, focusing on its progression and medical management options.

This study confirmed that 25(OH)D3 can be detected in hair samples from healthy young adults, but no correlation was found between hair and serum 25(OH)D3 concentrations, indicating limited potential as a standalone biomarker.

This review discusses the challenges of treating androgenic alopecia in Ukraine, highlighting the dominance of expensive, foreign-made cosmeceuticals and the need for effective, affordable plant-based alternatives; it reports no new clinical results.

This review discusses various physical therapies for androgenetic alopecia, reporting that low-level laser therapy has the most evidence but highlighting other promising treatments, such as non-ablative lasers and multimodal approaches, that warrant further investigation.

This research addresses the common concern of hair loss, often seen in post-COVID syndrome and other systemic conditions, and highlights uncertainties around its causes, diagnostic criteria, and the necessity for medical consultation, with implications for patient psychological wellbeing.

This study suggests that nanostructured lipid carriers loaded with spironolactone might improve localized delivery to hair follicles for treating androgenic alopecia, potentially minimizing systemic side effects.

This review highlights the use of natural products in cosmetic-containing herbals for skin and hair care but reports no new clinical results, calling attention to their claimed curative properties and minimal side effects.

This study introduced and validated new spectrophotometric methods to simultaneously determine finasteride and tadalafil in Entadfi™ capsules with high sensitivity and without interference from excipients.

This study found that differently charged micelles influence the acid-base equilibria of cetirizine by altering its ionization constants, indicating potential interactions with biomolecules of various charges under physiological conditions.

This study found that the incidence of anterolateral leg alopecia among men aged 36-52 may be higher than previously reported.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

This review evaluated various physical treatments for androgenetic alopecia and highlighted that low-level laser therapy is well-supported by evidence. However, nonablative laser and multimodal approaches like PEMF-LLLT appear promising and warrant further investigation.